PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26141494-6	2015	RESULTS: In vitro binding potency for ixazomib to the hERG channel was weak (K i 24.9 muM; IC50 59.6 muM), and nonclinical telemetry studies showed no QT/QTc prolongation at doses up to 4.2 mg/m(2).	ixazomib	38-46	latexin	Homo sapiens	86-89	
26141494-6	2015	RESULTS: In vitro binding potency for ixazomib to the hERG channel was weak (K i 24.9 muM; IC50 59.6 muM), and nonclinical telemetry studies showed no QT/QTc prolongation at doses up to 4.2 mg/m(2).	ixazomib	38-46	latexin	Homo sapiens	101-104